q3 earnings per share $1.15.
qtrly adjusted ebitda of $130 million, a recovery of 70% from 2019 levels.
expects capital expenditures for 2021 to be approximately $110 million, excluding impact of alg.
revpar in q3 of 2021 continued to recover at a robust pace, accelerating nearly 30%.
reaffirming its expectation for room growth to be greater than 6% for full year, excluding impact of alg.